2019-12-03 |
114 |
Notice of Service |
U.S. Patent No. 10,071,977; (2) Defendants' Amended Invalidity Contentions Regarding U.S. Patent No. 10,149,829…
7 May 2018
1:18-cv-00690
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2019-12-10 |
115 |
Notice of Service |
Supplemental Infringement Contentions for U.S. Patent No. 10,071,977 to Teva; and (2) Vanda's Supplemental Infringement…Infringement Contentions for U.S. Patent No. 10,071,977 to MSN filed by Vanda Pharmaceuticals Inc..(Fahnestock…
7 May 2018
1:18-cv-00690
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2019-12-23 |
118 |
Notice of Service |
Invalidity Contentions Concerning U.S. Patent No. 10,071,977 2) Defendants Second Amended Invalidity …Invalidity Contentions Regarding U.S. Patent No. 10,149,829 3) Defendants Third Amended Invalidity Contentions …
7 May 2018
1:18-cv-00690
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2020-01-30 |
122 |
Notice of Service |
. Regarding Infringement by MSN of U.S. Patent No. 10,071,977 filed by Vanda Pharmaceuticals Inc..(Jacobs…
7 May 2018
1:18-cv-00690
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2020-02-03 |
124 |
Notice of Service |
Report of Dr. Robert B. Perni Regarding U.S. Patent No. 10,071,977 (2) First Expert Report of Dr. Jonathan …
7 May 2018
1:18-cv-00690
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2020-03-30 |
129 |
Notice of Service |
Perni Regarding Non-Infringement of U.S. Patent No. 10,071,977 3) First Expert Report of Dr. John W. Winkelman…
7 May 2018
1:18-cv-00690
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2018-05-07 |
4 |
Patent/Trademark Report to Commissioner of Patents |
Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE46,604; 9,060,995; 9,539,234; 9,…2018
19 January 2022
1:18-cv-00690
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |